Hunan Warrant Pharmaceutical Co. Ltd. A Cash Flow Quality Index

Latest as of December 2024: 0.87x

Hunan Warrant Pharmaceutical Co. Ltd. A cash flow quality index. Hunan Warrant Pharmaceutical Co. Ltd. A (688799) has a Cash Flow Quality Index of 0.87x as of December 2024. Operating cash flow of CN¥142.23 Million is below net income of CN¥164.32 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 688799 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

0.87x
Operating CF / Net Income

Operating Cash Flow

CN¥142.23 Million
CNY

Net Income

CN¥164.32 Million
CNY

Data as of

Dec 2024
Most recent filing

Cash Flow Quality Index of Hunan Warrant Pharmaceutical Co. Ltd. A (2019–2024)

Cash flow quality index of Hunan Warrant Pharmaceutical Co. Ltd. A from 2019 to 2024. Historical Cash Flow Quality Index for Hunan Warrant Pharmaceutical Co. Ltd. A across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. See Hunan Warrant Pharmaceutical Co. Ltd. A (688799) net asset quality to measure how much of total assets are equity-financed.

Hunan Warrant Pharmaceutical Co. Ltd. A Cash Flow Quality Index by Year (2019–2024)

Hunan Warrant Pharmaceutical Co. Ltd. A cash flow quality index by year from 2019 to 2024. Year-by-year earnings quality comparison for Hunan Warrant Pharmaceutical Co. Ltd. A. For the full cash flow conversion analysis, see Hunan Warrant Pharmaceutical Co. Ltd. A (688799) cash flow conversion.

Year Quality Index Operating CF (CNY) Net Income YoY Change
2024 0.87x CN¥142.23 Million CN¥164.32 Million ▼ -14.7%
2023 1.01x CN¥214.44 Million CN¥211.37 Million ▲ +19.2%
2022 0.85x CN¥155.65 Million CN¥182.80 Million ▲ +19.3%
2021 0.71x CN¥114.72 Million CN¥160.76 Million ▼ -1.1%
2020 0.72x CN¥104.66 Million CN¥145.03 Million ▼ -28.2%
2019 1.01x CN¥116.66 Million CN¥116.01 Million —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.